- Partners Group acquired Pharmathen in January 2022
- Pharmathen is a complex drug delivery and formulation developer
- Partners Group is a global private markets firm based in Baar-Zug, Switzerland
Pharmathen, backed by Partners Group, has acquired CBL Patras, a vertically integrated peptides manufacturer.
CBL provides peptide starting materials and intermediates as well as industrial and commercial-scale manufacturing of proprietary and generic GMP peptides.
